Episode Details

Back to Episodes
India’s jet engine ambitions, Tata Sons' listing twist & a new weight-loss drug race| MC Editor's Picks

India’s jet engine ambitions, Tata Sons' listing twist & a new weight-loss drug race| MC Editor's Picks

Episode 4603 Published 9 months, 1 week ago
Description
India eyes a fighter jet engine partnership with France’s Safran post-Operation Sindoor, as delays hit GE supplies. Tata Sons faces fresh scrutiny over its listing exemption bid, with former CJI U U Lalit weighing in. Novo Nordisk races to launch Wegovy in India’s growing weight-loss market. Plus, a monsoon-led market watch, Assam’s semiconductor push, SEBI’s block deal revamp, and the global family office pivot toward India.
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us